Dr. John Cush RheumNow
1 year 7 months ago
13% of the ~22 million people with traditional coverage received a telehealth betw 10-12/2023. Expansion of Medicare telehealth coverage during the COVID-19 pandemic is set to expire on March 31 , 2025. Most telehealth will expire if Congress does not act. https://t.co/mVy7s664OX https://t.co/BVH6Hv5553
Dr. John Cush RheumNow
1 year 7 months ago
Retrospect. study of 77 RA pts w/ +ANCA (age 62 yrs, 79%F. 65% RF+. 45% p-ANCA+; 42% MPO+. Diagnoses included: AAV (29%); GPA (45%), MPA (36 %); EGPA (5%). Renal (41%) & upper Resp (36%) were most freq. Pts w/ RA+AAV had more RF, MPO+, nodules, inflam eye Dz… https://t.co/NTvAhZY2y8 https://t.co/IAkWHtcTCo
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!
Dr. John Cush RheumNow
1 year 7 months ago
CDC reports an unprecedented drop of ~24% in US drug overdose deaths (87,000 down from 114,000) in 12 mos prior to 9/24. Yet, overdose remains the leading cause of death for Americans aged 18-44 yrs https://t.co/REiaQx6NKd https://t.co/nzOMDgUYbS
A US study shows that nearly two-thirds of the population had suboptimal 5-year sleep duration trajectories with a resultant 29% increase in risk of all-cause mortality.
Dr. John Cush RheumNow
1 year 7 months ago
Schnitzler Syndrome: A Rare Autoinflammatory Disorder
A credible, quick overview
Chronic Urticaria
Monoclonal Gammopathy (
Recurrent Fever
Bone & Joint Pain
Elevated CRP &ESR https://t.co/boYFFEVwII https://t.co/xKCUZb8o6A
Dr. John Cush RheumNow
1 year 7 months ago
The global biosimilars market size is evaluated at USD $40 billion in 2025 and is expected to hit approximately USD 176 billion by 2034 (a 17.78% increase) https://t.co/U4PbinVN4J https://t.co/SLHynlhJrs
A study from the Lupus Hopkins Cohort shows that systemic lupus erythematosus (SLE) patients with pericarditis are at risk for recurrence, and likely to be younger patients, with uncontrolled disease, and linkage to higher doses of oral prednisone.
Dr. John Cush RheumNow
1 year 7 months ago
Diagnoses via Immune ‘Fingerprints’
Science and researchers at Stanford Medicine have reported the use of Mal-ID (machine learning for immunological diagnosis) to analyze B and T cell receptors (BCRs and TCRs) sequences from human blood, showing the ability to predict health… https://t.co/ni09ssCYSv https://t.co/4HWui3XxfE
Dr. John Cush RheumNow
1 year 7 months ago
Postoperative Weight Loss Improves Joint Replacement Survival
A cohort study of shows that postoperative weight loss with antiobesity medications significantly reduced the risk of 5-year and 10-year revision among patients with obesity undergoing hip or knee replacement.… https://t.co/u04Lc6DTT0 https://t.co/iZhEICFHUd
Dr. John Cush RheumNow
1 year 7 months ago
Cross-trait study of >300K patients’ electronic health records at UCSF and Stanford. Autoimmune conditions associate with greater Alzheimer’s risk (ORs 1.4–1.7). Women with autoimmune disorders have higher risk than men with autoimmune disorders https://t.co/bwtGhyNBs6 https://t.co/FNUdRNozCw
Dr. John Cush RheumNow
1 year 7 months ago
Cochrane review of TNF inhib. in #JIA shows TNFi efficacy, but uncertainty about LT safety, pain, function, & Dz control - esp compared to MTX. 9 studies, 678 JIApts, age 8-15 yrs (80% F), Dz duration 0.8-6.7 yrs. Withdrawls 1% v 3%; Serious AE 6% v 7% (PBO vs TNFi).… https://t.co/twmYfFg702 https://t.co/hG3j4sMPr9
Dr. John Cush RheumNow
1 year 7 months ago
RNA-seq analysis of human chondrocytes (HTC) shows Osteoarthritis has more HTC-1 (w/ more cell apoptosis & PD-1 genes) & proliferate fibrochondrocytes (ProFC2) w/ heightened inflammatory response, & increased cytokine signalling https://t.co/FZ72CnWk20 https://t.co/sx4NB2C8h3
JAMA Dermatology reports a retrospective cohort study from Johns Hopkins reviewing mimic of dermatomyositis (DM), suggesting that DM and especially clinically amyopathic DM (CADM) are commonly and initially misdiagnosed as inflammatory skin disease (ISD).The study was undertaken to evaluate misdiagnosis patterns and the clinical implications of those with DM and CADM.
